Mercury Laboratories Limited has announced that its Board of Directors approved the financial results for the quarter ended June 30, 2025, in a meeting on August 13, 2025. For this quarter, the company reported a total income of Rs 18.14 Cr and a net profit of Rs 0.10 Cr. This compares to a total income of Rs 16.68 Cr and a net profit of Rs 0.34 Cr in the same quarter last year. The company operates solely in Pharmaceuticals Products. Full financial results are available on the stock exchange and company websites.